| A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine (NCT02693652) | Aribio Lab Co., Ltd. | 2014-10-28 |
| A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study) (NCT02327416) | Tongji Hospital | 2014-10-01 |
| Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney Function (NCT02267473) | Johann Wolfgang Goethe University Hospital | 2014-10-01 |
| TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction (NCT02338674) | Fuzhou General Hospital | 2014-10-01 |
| Effect of RO6871765 and RO7011785 on Immune Response With the Stimulation of Peripheral Blood Mononuclear Cells (PBMCs) in Chinese Healthy Volunteers and Chronic Hepatitis B Patients (NCT02498275) | Hoffmann-La Roche | 2014-07-01 |
| Study of Therapeutic Vaccination With Intensified Schedule Plus Pegasys Dual Therapy on Chronic Hepatitis B Infection (NCT02097004) | Seoul National University Hospital | 2014-04-01 |
| Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity (NCT02148562) | Universitaire Ziekenhuizen KU Leuven | 2014-04-01 |
| Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy (NCT02081469) | Chang Gung Memorial Hospital | 2014-03-17 |
| A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection (NCT02065336) | Arrowhead Pharmaceuticals | 2014-03-01 |
| Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay (NCT02167113) | Hologic, Inc. | 2014-03-01 |
| HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy (NCT03350074) | Central Hospital, Nancy, France | 2013-11-05 |
| A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue (NCT01855997) | Hoffmann-La Roche | 2013-08-20 |
| Phase Ⅲ Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg-positive Chronic Hepatitis B (NCT02366247) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2013-08-01 |
| Renoprotective Effects of Telbivudine in Chronic Hepatitis B (NCT03778567) | The University of Hong Kong | 2013-08-01 |
| Combination Therapy With Interferon Plus Interleukin 2 and Hepatitis B Vaccine in Chronic Hepatitis B Patients (NCT02360592) | Tongji Hospital | 2013-06-01 |
| Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease (NCT02128503) | Chinese University of Hong Kong | 2013-02-01 |
| A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression (NCT01706575) | Hoffmann-La Roche | 2013-01-01 |
| A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450) (NCT01641926) | Merck Sharp & Dohme LLC | 2012-11-26 |
| An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B (NCT01730508) | Hoffmann-La Roche | 2012-11-20 |
| A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253 (NCT01697501) | Hoffmann-La Roche | 2012-11-08 |
| Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B (NCT02726789) | Replicor Inc. | 2012-10-01 |
| HBsAg Related Response Guided Therapy (NCT01456312) | Gangnam Severance Hospital | 2012-09-01 |
| A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B (NCT01519960) | Hoffmann-La Roche | 2012-07-11 |
| A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B (NCT01705704) | Hoffmann-La Roche | 2012-06-01 |
| Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects (NCT01480622) | GlaxoSmithKline | 2011-12-05 |
| Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B With Poor Response to Other Drugs (NCT01475851) | GlaxoSmithKline | 2011-12-01 |
| Phase 3 Study of GSK548470 in Patients With Compensated Chronic Hepatitis B Untreated With Nucleic Acid Analogue (NCT01480284) | GlaxoSmithKline | 2011-11-01 |
| Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients (NCT01641536) | Genexine, Inc. | 2011-11-01 |
| PROLIFICA - West African Treatment Cohort for Hepatitis B (NCT02129829) | Imperial College London | 2011-10-01 |
| EFFORT Extension Study (NCT01529255) | Nanfang Hospital, Southern Medical University | 2011-08-01 |
| Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients (NCT02646189) | Replicor Inc. | 2011-08-01 |
| An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B (NCT01667432) | Hoffmann-La Roche | 2011-07-08 |
| Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B (NCT02366208) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2011-05-01 |
| A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265 (NCT01645969) | Hoffmann-La Roche | 2011-04-01 |
| Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection (NCT01341106) | RWTH Aachen University | 2011-04-01 |
| Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B (NCT01311947) | China Medical University Hospital | 2011-03-01 |
| Lamivudine and Adefovir Dipivoxil Fixed Dose Combination (NCT01353742) | GlaxoSmithKline | 2011-02-21 |
| Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients (NCT01356901) | Bristol-Myers Squibb | 2011-01-01 |
| A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B. (NCT01179594) | Hoffmann-La Roche | 2010-09-18 |
| The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer (NCT01310062) | Ministry of Health, Malaysia | 2010-08-01 |
| Lamivudine(LAM) Good Responder Study (NCT01128686) | ViiV Healthcare | 2010-08-01 |
| Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B. (NCT01220596) | Hanyang University | 2010-06-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B (NCT00922207) | Hoffmann-La Roche | 2010-05-07 |
| A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg Positive (NCT01086085) | Hoffmann-La Roche | 2010-04-01 |
| Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation (NCT00800787) | Biotest Pharmaceuticals Corporation | 2010-04-01 |
| Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B (NCT02075294) | Ying-Jie Ji | 2010-01-01 |
| Entecavir Plus Adefovir in Lamivudine-Resistant Patients (NCT00986778) | Bristol-Myers Squibb | 2009-12-01 |
| Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection (NCT01107483) | Sun Yat-sen University | 2009-12-01 |
| Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir (NCT01023217) | Asan Medical Center | 2009-11-01 |
| A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous Studies (NCT00962975) | Hoffmann-La Roche | 2009-09-01 |
| A Study to Assess DV-601 in Subjects With Chronic Hepatitis B (NCT01023230) | Dynavax Technologies Corporation | 2009-09-01 |
| A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both (NCT00962871) | Hoffmann-La Roche | 2009-08-01 |
| EFFicacy Optimization Research of Telbivudine Therapy (NCT00962533) | Nanfang Hospital, Southern Medical University | 2009-08-01 |
| Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy (NCT01090531) | Johann Wolfgang Goethe University Hospital | 2009-08-01 |
| Epidemiological Study in Children and Adolescents With Chronic Hepatitis B (NCT01163240) | Novartis Pharmaceuticals | 2009-06-01 |
| An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas) (NCT01283074) | Hoffmann-La Roche | 2009-05-01 |
| Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB) (NCT01155427) | Bristol-Myers Squibb | 2009-05-01 |
| An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys (NCT01011738) | Hoffmann-La Roche | 2009-04-11 |
| A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B (NCT00940485) | Hoffmann-La Roche | 2009-04-01 |
| A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B (NCT00927082) | Hoffmann-La Roche | 2009-04-01 |
| A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B (NCT00815464) | Yu Medical Garden | 2009-03-01 |
| Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease Patients (NCT00823550) | Yonsei University | 2009-01-01 |
| Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients (NCT02646163) | Replicor Inc. | 2009-01-01 |
| ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B (NCT00661076) | Hoffmann-La Roche | 2008-08-01 |
| Suboptimal Responders to Adefovir Switching to Entecavir (NCT00718887) | Bristol-Myers Squibb | 2008-07-01 |
| Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B (NCT00646503) | Novartis | 2008-03-01 |
| Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine (NCT00640588) | Novartis Pharmaceuticals | 2008-03-01 |
| Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus (NCT00410202) | Bristol-Myers Squibb | 2008-03-01 |
| Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNA (NCT00625339) | Yonsei University | 2008-02-01 |
| Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA (NCT00637663) | Pusan National University Hospital | 2008-02-01 |
| A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB) (NCT00651209) | Novartis Pharmaceuticals | 2008-02-01 |
| Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA (NCT00625560) | Yonsei University | 2008-02-01 |
| Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B (NCT00860626) | Sun Yat-sen University | 2008-01-01 |
| "Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu (NCT03097952) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2008-01-01 |
| PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327) (NCT00536263) | Merck Sharp & Dohme LLC | 2007-09-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B. (NCT00460850) | Hoffmann-La Roche | 2007-09-01 |
| To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB) (NCT00537537) | Novartis Pharmaceuticals | 2007-08-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B. (NCT00614471) | Hoffmann-La Roche | 2007-08-01 |
| A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection (NCT00423891) | Bristol-Myers Squibb | 2007-06-30 |
| Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load (NCT01013272) | The University of Hong Kong | 2007-06-01 |
| Laboratory Profile of Hepatitis B and C in Users of a Reference Service (NCT00512941) | UPECLIN HC FM Botucatu Unesp | 2007-06-01 |
| Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection (NCT00395018) | Bristol-Myers Squibb | 2007-04-01 |
| Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B (NCT00410072) | Bristol-Myers Squibb | 2007-04-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB). (NCT00435825) | Hoffmann-La Roche | 2007-03-01 |
| A Study of Peginterferon Alfa-2a (40KD) (PEGASYS®) in Participants With Hepatitis B Envelope Antigen (HBeAg) - Positive Chronic Hepatitis B (NCT00436163) | Hoffmann-La Roche | 2007-03-01 |
| Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B (NCT00917761) | National Taiwan University Hospital | 2007-02-01 |
| Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B (NCT00921180) | National Taiwan University Hospital | 2007-02-01 |
| Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions (NCT01908660) | Valme University Hospital | 2007-01-01 |
| Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection (NCT00810524) | Sun Yat-sen University | 2007-01-01 |
| SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB). (NCT00442572) | Hoffmann-La Roche | 2006-07-03 |
| Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814 (NCT00403585) | GlaxoSmithKline | 2006-07-01 |
| Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis) (NCT01376154) | GlaxoSmithKline | 2006-06-01 |
| An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B (NCT01787279) | Hoffmann-La Roche | 2006-01-01 |
| Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603) (NCT00686790) | Merck Sharp & Dohme LLC | 2005-12-01 |
| A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (NCT02598063) | Hoffmann-La Roche | 2005-10-01 |
| A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B. (NCT01519921) | Hoffmann-La Roche | 2005-10-01 |
| Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253 (NCT01237496) | Hoffmann-La Roche | 2005-07-01 |
| Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201 (NCT00230490) | Bausch Health Americas, Inc. | 2005-06-01 |
| Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis (NCT00347009) | GlaxoSmithKline | 2005-05-01 |
| A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV) (NCT01095835) | Hoffmann-La Roche | 2005-02-01 |